Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy

dc.contributor.authorThaweerat W.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:54:40Z
dc.date.available2023-06-18T17:54:40Z
dc.date.issued2022-03-01
dc.identifier.citationAnnals of Nuclear Medicine Vol.36 No.3 (2022) , 327-328
dc.identifier.doi10.1007/s12149-021-01712-6
dc.identifier.eissn18646433
dc.identifier.issn09147187
dc.identifier.pmid35094260
dc.identifier.scopus2-s2.0-85123831337
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/86081
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleOptimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85123831337&origin=inward
oaire.citation.endPage328
oaire.citation.issue3
oaire.citation.startPage327
oaire.citation.titleAnnals of Nuclear Medicine
oaire.citation.volume36
oairecerif.author.affiliationSiriraj Hospital

Files

Collections